XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Stockholders' Deficit (unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interests
Beginning balance (in shares) at Dec. 31, 2021       166,901 320        
Beginning balance at Dec. 31, 2021 $ 83.2     $ 0.2 $ 0.0 $ 1,594.7 $ (1,474.6) $ (38.6) $ 1.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 68.6           68.4   0.2
Equity-based compensation, including amounts capitalized 62.2         62.2      
Stock option exercises (in shares)       202          
Stock option exercises 8.5         8.5      
Repurchases of Class A common stock (in shares)       (6,532)          
Repurchases of Class A common stock (750.2)           (750.2)    
Impact of derivatives, net 93.1             93.1  
Change in foreign currency translation adjustment (34.3)             (34.3)  
Vesting of restricted stock units and other (in shares)       1,115 8        
Vesting of restricted stock units and other 0.2         0.2   (0.1) 0.1
Ending balance (in shares) at Mar. 31, 2022       161,686 312        
Ending balance at Mar. 31, 2022 (468.7)     $ 0.2 $ 0.0 1,665.6 (2,156.4) 20.1 1.8
Beginning balance (in shares) at Dec. 31, 2021       166,901 320        
Beginning balance at Dec. 31, 2021 83.2     $ 0.2 $ 0.0 1,594.7 (1,474.6) (38.6) 1.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 259.1                
Ending balance (in shares) at Sep. 30, 2022       155,704 312        
Ending balance at Sep. 30, 2022 (276.0)     $ 0.2 $ 0.0 1,827.8 (2,312.1) 205.7 2.4
Beginning balance (in shares) at Mar. 31, 2022       161,686 312        
Beginning balance at Mar. 31, 2022 (468.7)     $ 0.2 $ 0.0 1,665.6 (2,156.4) 20.1 1.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 90.5           90.4   0.1
Equity-based compensation, including amounts capitalized 67.5         67.5      
Stock option exercises (in shares)       158          
Stock option exercises 4.9         4.9      
Repurchases of Class A common stock (in shares)       (6,059)          
Repurchases of Class A common stock (236.3)           (236.3)    
Issuance of Class A common stock under Employee Stock Purchase Plan (ESPP) (in shares)       302          
Issuance of Class A common stock under Employee Stock Purchase Plan (ESPP) 18.4         18.4      
Impact of derivatives, net 69.7             69.7  
Change in foreign currency translation adjustment 9.0             9.0  
Vesting of restricted stock units and other (in shares)       458          
Vesting of restricted stock units and other (0.3)         (0.1)   (0.2)  
Ending balance (in shares) at Jun. 30, 2022       156,545 312        
Ending balance at Jun. 30, 2022 (445.3)     $ 0.2 $ 0.0 1,756.3 (2,302.3) 98.6 1.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 100.0           99.8   0.2
Equity-based compensation, including amounts capitalized 66.1         66.1      
Stock option exercises (in shares)       138          
Stock option exercises 5.4         5.5     (0.1)
Repurchases of Class A common stock (in shares)       (1,466)          
Repurchases of Class A common stock (109.6)           (109.6)    
Impact of derivatives, net 101.9             101.9  
Change in foreign currency translation adjustment 5.4             5.4  
Vesting of restricted stock units and other (in shares)       487          
Vesting of restricted stock units and other 0.1         (0.1)   (0.2) 0.4
Ending balance (in shares) at Sep. 30, 2022       155,704 312        
Ending balance at Sep. 30, 2022 (276.0)     $ 0.2 $ 0.0 1,827.8 (2,312.1) 205.7 2.4
Beginning balance (in shares) at Dec. 31, 2022   153,830 312 153,830 312        
Beginning balance at Dec. 31, 2022 (329.3)     $ 0.2 $ 0.0 1,912.6 (2,422.6) 178.0 2.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 47.4           47.3   0.1
Equity-based compensation, including amounts capitalized 74.5         74.5      
Stock option exercises (in shares)       132          
Stock option exercises 3.2         3.2      
Repurchases of Class A common stock (in shares)       (1,553)          
Repurchases of Class A common stock (113.9)           (113.9)    
Impact of derivatives, net (39.5)             (39.5)  
Change in foreign currency translation adjustment 2.1             2.1  
Vesting of restricted stock units and other (in shares)       1,705 5        
Vesting of restricted stock units and other 0.0         0.2 (0.1) 0.1 (0.2)
Ending balance (in shares) at Mar. 31, 2023       154,114 307        
Ending balance at Mar. 31, 2023 (355.5)     $ 0.2 $ 0.0 1,990.5 (2,489.3) 140.7 2.4
Beginning balance (in shares) at Dec. 31, 2022   153,830 312 153,830 312        
Beginning balance at Dec. 31, 2022 (329.3)     $ 0.2 $ 0.0 1,912.6 (2,422.6) 178.0 2.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 261.5                
Ending balance (in shares) at Sep. 30, 2023   141,989 307 141,989 307        
Ending balance at Sep. 30, 2023 (973.4)     $ 0.1 $ 0.0 2,170.0 (3,315.3) 168.9 2.9
Beginning balance (in shares) at Mar. 31, 2023       154,114 307        
Beginning balance at Mar. 31, 2023 (355.5)     $ 0.2 $ 0.0 1,990.5 (2,489.3) 140.7 2.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 83.1           82.9   0.2
Equity-based compensation, including amounts capitalized 78.0         78.0      
Stock option exercises (in shares)       115          
Stock option exercises 1.5         1.6     (0.1)
Repurchases of Class A common stock (in shares) [1]       (7,019)          
Repurchases of Class A common stock [1] (511.6)     $ (0.1)     (511.5)    
Issuance of Class A common stock under Employee Stock Purchase Plan (ESPP) (in shares)       299          
Issuance of Class A common stock under Employee Stock Purchase Plan (ESPP) 18.2         18.2      
Impact of derivatives, net 17.8             17.8  
Change in foreign currency translation adjustment 3.9             3.9  
Vesting of restricted stock units and other (in shares)       784          
Vesting of restricted stock units and other 0.1         (0.1) 0.1   0.1
Ending balance (in shares) at Jun. 30, 2023       148,293 307        
Ending balance at Jun. 30, 2023 (664.5)     $ 0.1 $ 0.0 2,088.2 (2,917.8) 162.4 2.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Excised tax on share repurchases 3.8                
Net income 131.0           130.7   0.3
Equity-based compensation, including amounts capitalized 76.7         76.7      
Stock option exercises (in shares)       59          
Stock option exercises 4.9         4.9      
Repurchases of Class A common stock (in shares) [1]       (7,166)          
Repurchases of Class A common stock [1] (528.2)           (528.2)    
Impact of derivatives, net 16.5             16.5  
Change in foreign currency translation adjustment (9.9)             (9.9)  
Vesting of restricted stock units and other (in shares)       803          
Vesting of restricted stock units and other 0.1         0.2   (0.1)  
Ending balance (in shares) at Sep. 30, 2023   141,989 307 141,989 307        
Ending balance at Sep. 30, 2023 (973.4)     $ 0.1 $ 0.0 $ 2,170.0 $ (3,315.3) $ 168.9 $ 2.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Excised tax on share repurchases $ 4.6                
[1] Includes a 1% excise tax on shares repurchased, net of the fair market value of new share issuances, of $4.6 million.